Aug. 8, 2025
— Jeff Ward, Lehigh Valley News Briefs
Shares of OraSure (NASDAQ:OSUR) traded at $2.68 as of 10:28 a.m. today.
They’ve been falling since the company announced another quarterly loss and another big dip in revenue.
At $2.68, the shares are trading below estimated cash per share of $3.31, according to Yahoo Finance. And that with almost no debt.
The cash per share may serve as a floor on the price, but how low can it go?
The shares have been falling since the end of the COVID-19 pandemic, when federal largesse boosted the prospects of the maker of medical diagnostic devices such as InteliSwab and OraQuick.
OraSure’s second-quarter numbers were expected, Chief Executive Carrie Eglinton Manner said on Tuesday.
Perhaps investors prefer companies that don’t expect and deliver bad news, couched in optimistic jargon about “three pillars of transformation.”
The company’s third-quarter revenue is forecast to be even lower.
At some point the institutional investors who ultimately control the company may get tired of it.
Right now they have bigger things on their mind than their stakes in a Bethlehem-based company with a market capitalization of $199 million.
Lehigh Valley News Briefs 